ArticleThe Prostate2025

In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer.

Justine Habault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.